Primary pericardial mesothelioma: a case report of a patient treated with an immune checkpoint inhibitor as the second-line treatment
Acta Oncol
.
2021 May;60(5):687-691.
doi: 10.1080/0284186X.2021.1887515.
Epub 2021 Feb 23.
Authors
Otso Arponen
1
2
,
Virpi Salo
1
,
Annika Lönnberg
3
,
Leila Vaalavirta
4
,
Hannu Koivu
5
,
Paul Nyandoto
4
6
Affiliations
1
Department of Radiology, Päijät-Häme Central Hospital, Lahti, Finland.
2
Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
3
Department of Cardiology, Päijät-Häme Central Hospital, Lahti, Finland.
4
Department of Oncology, Helsinki University Hospital, Helsinki, Finland.
5
Department of Nuclear Medicine, Päijät-Häme Central Hospital, Lahti, Finland.
6
Department of Oncology, Päijät-Häme Central Hospital, Lahti, Finland.
PMID:
33620252
DOI:
10.1080/0284186X.2021.1887515
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Heart Neoplasms*
Humans
Immune Checkpoint Inhibitors
Mesothelioma* / drug therapy
Mesothelioma, Malignant*
Thymus Neoplasms*
Substances
Immune Checkpoint Inhibitors